✉ info@591daili.com☎ +86-18553102138
📞 WhatsApp中文
591daili 济南圣和化工
Home › Product Catalog › carteolol hydrochloride

carteolol hydrochloride

CAS 51781-21-6C16H25ClN2O3MW 328.83

carteolol hydrochloride (CAS No. 51781-21-6) is supplied by Jinan Shenghe Chemical Co., Ltd. with a typical purity of 按批次COA提供(不公开发布). Main applications include Pharmaceutical Intermediates & APIs. Bulk quantities are available with COA; purity and packaging are subject to batch COA and order confirmation.

Specifications

CAS Number51781-21-6
Molecular FormulaC16H25ClN2O3
Molecular Weight328.83
Purity按批次COA提供(不公开发布)
Packaging按订单/批次确认(不公开发布)
ApplicationsPharmaceutical Intermediates & APIs
CategoryPharmaceutical Intermediates & APIs

Where it is used

Pharmaceutical Intermediates & APIs

Packaging & Supply

Packaging按订单/批次确认(不公开发布)
Purity按批次COA提供(不公开发布)
StorageSealed, cool and dry place
Lead TimeIn stock / per order

Documents & Support

COA provided with every batch; MSDS and technical documents available on request. Email us with product name and CAS number for a quote within one business day.

Frequently Asked Questions

What is the CAS number of carteolol hydrochloride?

The CAS number of carteolol hydrochloride is 51781-21-6.

What purity and packaging are available?

Typical purity is 按批次COA提供(不公开发布), supplied in 按订单/批次确认(不公开发布), with COA provided.

What are the applications of carteolol hydrochloride?

Main applications include Pharmaceutical Intermediates & APIs.

How do I buy carteolol hydrochloride or get a quote?

Email info@591daili.com or reach us on WhatsApp with the product name, CAS number and required quantity; quotes within one business day. Supplier: Jinan Shenghe Chemical Co., Ltd..

PubChem Public Data

Description

carteolol hydrochloride · CAS 51781-21-6 · C16H25ClN2O3. UNII 4797W6I0T4.

Identification

CAS Registry Number51781-21-6
PubChem CID40127
Molecular formulaC16H25ClN2O3
IUPAC name5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one;hydrochloride
UNII (FDA)4797W6I0T4

Computed Descriptors

Molecular Weight328.83
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count4
Rotatable Bond Count6
Exact Mass328.1553704
Monoisotopic Mass328.1553704
Topological Polar Surface Area70.6
Heavy Atom Count22
Formal Charge0
Complexity354

Regulatory Status

GHS notification summary16.7% (1 / 6)

GHS Hazard Classification

GHS notification summary16.7% (1 / 6)
Reported hazard statementsH302 (83.3%), H319 (33.3%), H351 (16.7%), H361 (50%)

This chemical does not meet GHS hazard criteria for 16.7% (1 of 6) of reports.

H302 (83.3%): Harmful if swallowed [Warning Acute toxicity, oral]

Documented Uses

  • Breast Feeding; Lactation; Milk, Human; Adrenergic Beta-Antagonists; Antiglaucoma Agents
  • Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
  • Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
  • Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
  • Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.
  • Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]

Synonyms

carteolol hydrochloride; 51781-21-6; Carteolol HCl; Cartrol; Ocupress; Abbott-43326; OPC-1085; Teoptic; DTXSID4045478; NSC-300906; 4797W6I0T4; DTXCID2025478; 5-(2-Hydroxy-3-tert-butylamino)propoxy-3,4-dihydrocarbostyril hydrochloride; 5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydrocarbostyril monohydrochloride; NSC300906; 5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-2(1H)-quinolinone hydrochloride

Frequently Asked Questions

What are the CAS number and molecular formula of carteolol hydrochloride?

CAS 51781-21-6; molecular formula C16H25ClN2O3; molecular weight — g/mol.

What other names is carteolol hydrochloride known by?

carteolol hydrochloride, 51781-21-6, Carteolol HCl, Cartrol, Ocupress, Abbott-43326.

Is carteolol hydrochloride classified as hazardous?

16.7% of GHS notifications report no hazard classification (1 of 6).

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

You may also need

Get a quote for carteolol hydrochloride

Supplier: Jinan Shenghe Chemical Co., Ltd. · Reply within one business day.

Email Inquiry WhatsApp
鲁ICP备19031700号-1